Table 1.
Baseline characteristics
| Characteristic | All (n=2,181) | Control (n=1,273) | Case (n=908) | p |
|---|---|---|---|---|
| Age (years) | 65 ± 8 | 65 ± 8 | 66 ± 8 | 0.002 |
| Male (%) | 65 | 65 | 65 | 0.969 |
| Diabetes (%) | 3.7 | 1.6 | 6.5 | <0.001 |
| Smoking (%) | 63.0 | 58.7 | 69.2 | <0.001 |
| LDL-C (mmol/L) | 4.0 (3.4–4.8) | 4.0 (3.3–4.7) | 4.2 (3.6–4.9) | <0.001 |
| HDL-C (mmol/L) | 1.3 (1.0–1.5) | 1.3 (1.1–1.6) | 1.2 (1.0–1.5) | <0.001 |
| Triglycerides (mmol/L) | 1.8 (1.3–2.5) | 1.6 (1.2–2.3) | 1.9 (1.4–2.7) | <0.001 |
| TMAO (μM) | 3.4 (2.3–5.7) | 3.3 (2.2–5.2) | 3.7 (2.5–6.4) | <0.001 |
| Choline (μM) | 9.0 (7.7–10.3) | 8.9 (7.7–10.1) | 9.1 (7.9–10.5) | 0.001 |
| Betaine (μM) | 31.0 (25.3–37.2) | 31.2 (25.6–37.2) | 30.8 (25–37.3) | 0.659 |
Expressed in mean ± standard deviation or median (interquartile range) Abbreviation: LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.